These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7580549)
1. Increasing prescription of drugs for secondary prevention after myocardial infarction. Smith J; Channer KS BMJ; 1995 Oct; 311(7010):917-8. PubMed ID: 7580549 [No Abstract] [Full Text] [Related]
2. Increasing prescription of drugs for secondary prevention of myocardial infarction. Authors' recommendations are too restrictive. Sapsford RJ; Robinson MB; Hall AS BMJ; 1996 Jan; 312(7025):252. PubMed ID: 8563612 [No Abstract] [Full Text] [Related]
3. Clinical trials versus clinical practice in the secondary prevention of myocardial infarction. Agustí A; Arnau JM; Laporte JR Eur J Clin Pharmacol; 1994; 46(2):95-9. PubMed ID: 7913683 [TBL] [Abstract][Full Text] [Related]
4. [Drug prescription in the postinfarction period; results of the EPPI II (Study of Postinfarct Prescription). A French cooperative study]. Boissel JP; Némoz C; Leizorovicz A; Gillet J Arch Mal Coeur Vaiss; 1995 Sep; 88(9):1261-6. PubMed ID: 8526704 [TBL] [Abstract][Full Text] [Related]
5. Audit of secondary prophylaxis after myocardial infarction. Whitford DL; Southern AJ BMJ; 1994 Nov; 309(6964):1268-9. PubMed ID: 7888849 [No Abstract] [Full Text] [Related]
6. [Drug prescription in myocardial postinfarction: results of the EPPI (étude de prescription postinfarctus). A French cooperative study]. Boissel JP; Némoz C; Gillet J; Salewski B; Diaz N Arch Mal Coeur Vaiss; 1990 Nov; 83(12):1777-82. PubMed ID: 1980055 [TBL] [Abstract][Full Text] [Related]
7. The role of pharmacotherapy in secondary prevention of myocardial infarction and death. Gorlin R; Fuster V Mt Sinai J Med; 1984 Jun; 51(3):229-36. PubMed ID: 6146929 [No Abstract] [Full Text] [Related]
8. [Secondary prevention after myocardial infarction--beta blockade and acetylsalicylic acid is the basic therapy]. Bergstrand R; Johansson S; Ulvenstam G; Aberg A; Wilhelmsen L Lakartidningen; 1989 Jan; 86(1-2):47-50. PubMed ID: 2562999 [No Abstract] [Full Text] [Related]
10. An audit of discharge medication for secondary prophylaxis post-myocardial infarction. Richardson J; Truman C J Clin Pharm Ther; 1996 Dec; 21(6):413-6. PubMed ID: 9201568 [TBL] [Abstract][Full Text] [Related]
11. Beta-blockers and antithrombotics for secondary prevention after myocardial infarction. Ball SG Eur Heart J; 1998 Jan; 19(1):14-5. PubMed ID: 9503172 [No Abstract] [Full Text] [Related]
12. Secondary prevention of coronary heart disease in patients after acute myocardial infarction at the Soroka Medical Center. Rubowitz AH; Porath A Isr J Med Sci; 1992 Dec; 28(12):856-61. PubMed ID: 1363097 [TBL] [Abstract][Full Text] [Related]
13. [Secondary prevention after myocardial infarction]. Preobrazhenskiĭ DV Kardiologiia; 1993; 33(4):72-9. PubMed ID: 7933799 [No Abstract] [Full Text] [Related]
14. [Secondary prevention following a myocardial infarct]. Enjalbert M; Théroux P; Bourassa MG Union Med Can; 1983 Mar; 112(3):219-20, 225-8, 234. PubMed ID: 6134369 [No Abstract] [Full Text] [Related]
15. [Prevention of secondary myocardial infarction]. Degeorges M; Boissel JP; Guermonprez JL; Sultan Y; Weber S Sem Hop; 1981 Oct 18-25; 57(39-40):1623-5. PubMed ID: 6119791 [No Abstract] [Full Text] [Related]
16. Management of myocardial infarction from the patient. Rodgers KA N Z Med J; 1994 Apr; 107(975):140-1. PubMed ID: 7908426 [No Abstract] [Full Text] [Related]
17. [Prevention of myocardial infarction by chemotherapy]. Toshima H; Adachi K Nihon Rinsho; 1982; 40(11):2465-70. PubMed ID: 6130172 [No Abstract] [Full Text] [Related]